Mr. Córdoba, reporting to Roger Dumoulin-White, President and CEO, will have general management responsibilities over the sales, marketing, production, clinical services and regulatory affairs departments.
Mr. Córdoba has over 16 years of experience in leading numerous high technology manufacturing companies to success, providing general management expertise in local and international sales, marketing, production, operations and regulatory affairs.
His last position, prior to joining Theralase, was as Director Of Operations for a $17 million aerospace organization turnaround situation, in which Mr. Córdoba, through a number of different initiatives, achieved an increase in productivity of over 400 per cent in less than two years. Prior to that, Mr. Córdoba, in the capacity of a Project Operations Manager, successfully launched a 250,000 square foot, $40 million facility for manufacturing high precision assemblies for a division of Magna Inc. In an earlier position, he was the sales and marketing manager for a high tech equipment manufacturer, responsible for sales in excess of $10 million annually.
"I am excited to be part of such a world-class medical organization as Theralase. Under the direction of Roger Dumoulin-White, Theralase has systematically developed valuable intellectual property in the medical laser space and in my estimation is now positioned to rapidly execute on its growth strategy," said Jorge Córdoba. "I accepted the position because Theralase has such wonderful upside, attracting a dedicated team of professionals able to take this intellectual property to the next level and dramatically increase its revenue over the next few years. I look forward to following in Roger’s footsteps to dramatically grow the therapeutic division of the Company."
Mr. Córdoba obtained a Master’s of Business from the Ivey School of Business, University of Western Ontario, London, Ontario in 2005, a Master’s of Science in Advanced Manufacturing Technology from the University of Manchester, Manchester, England in 1993 and a Bachelor of Mechanical-Electrical Engineering from the National University, Mexico City, Mexico in 1989.
"It is a pleasure to have someone with Jorge’s background and experience join Theralase to grow the therapeutic laser division in Canada, the United States and internationally," said Roger Dumoulin- White, President & CEO of Theralase Technologies Inc. "I look forward to focusing on commercializing the patented Photo Dynamic Compounds (PDCs) for cancer destruction and bacterial sterilization applications, as I transfer my knowledge on the therapeutic medical laser technology to Jorge, so he can adopt my vision for Theralase and put his own mark on it in 2011 and beyond."